SureSelect Human Methyl-Seq Kits
Agilent SureSelectXT Human Methyl-Seq is the first comprehensive target enrichment system to enable researchers to focus on the regions where methylation is known to impact gene regulation. It targets the most complete Methyl-Seq content, including cancer tissue-specific DMRs, GENCODE promoters, CpG islands, shores and shelves ±4kb, DNaseI hypersensitive sites and RefGenes. • Delivers more information than methylation microarr…
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Agilent SureSelectXT Human Methyl-Seq is the first comprehensive target enrichment system to enable researchers to focus on the regions where methylation is known to impact gene regulation. It targets the most complete Methyl-Seq content, including cancer tissue-specific DMRs, GENCODE promoters, CpG islands, shores and shelves ±4kb, DNaseI hypersensitive sites and RefGenes.
• Delivers more information than methylation microarrays by detecting individual CpGs
• Increases throughput, reduces costs compared to Whole-genome Bisulfite Sequencing
• Reveals methylated regions undetected by RRBS and MeDIP
